Another D.C.-area company that provides contract work for USAID has announced mass layoffs as the Trump administration moves ...

New Delhi: Tamarind Global, a homegrown destination management company, has launched a brand-new logo as part of its transformative brand revamp. More than just a visual update, the new logo ...

We recently published a list of the 10 Best Drug Stocks to Buy Now. In this article, we are going to take a look at where ...

The extra power is accompanied by several carbon fiber parts and aero enhancements. ABT has also worked its magic on the RS Q8’s advanced suspension. The Audi RS Q8 may not have the same appeal ...

Abbott (NYSE: ABT) recently reported its Q4 results, with revenues marginally below and earnings meeting the street expectations. The company reported revenue of $10.97 billion and earnings of $1. ...

2025 Adjusted Tax Rate Forecast: 16% to 17%. Abbott Laboratories (NYSE:ABT) achieved a 9.5% sales growth excluding COVID testing, demonstrating strong performance across its business segments.

In a report released yesterday, David Toung from Argus Research maintained a Buy rating on Abbott Laboratories (ABT – Research Report). The company’s shares opened today at $129.75.

Abbott’s ABT diversified business portfolio is well-positioned to drive continued momentum in 2025. Yet, the international ...

and the significant investments we've made to expand manufacturing capacity to serve the growing global demand for our products. Moving to diagnostics, where sales increased 6%, excluded COVID ...

Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Abbott Laboratories (ABT – Research Report) today and set a price target of $136.00. The company’s shares closed yesterday at ...